2024年3月28日 · Qelbree is a once-a-day treatment for attention deficit hyperactivity disorder (ADHD) in adults and children 6 years of age and older. Qelbree is a non-stimulant ADHD medicine that may help to improve attention and reduce hyperactivity and impulsiveness.

2024年7月21日 · Qelbree (viloxazine) is commonly used to treat attention deficit hyperactivity disorder (ADHD). Qelbree may also be used for other conditions as determined by your healthcare provider.

Qelbree ® (viloxazine extended-release capsules) is a prescription medicine used to treat ADHD in adults and children 6 years and older. Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment or when the dose is changed.

Qelbree (Generic Name: viloxazine) is a non-stimulant ADHD medication containing a serotonin norepinephrine modulating agent approved by the FDA to treat attention deficit hyperactivity disorder (ADHD or ADD) in adults and children over six years of age.

2023年7月24日 · Qelbree (viloxazine) is a prescription drug that’s used to treat attention deficit hyperactivity disorder (ADHD). Qelbree comes as an oral capsule. Qelbree is prescribed for use in adults and...

2025年1月31日 · Detailed dosage guidelines and administration information for Qelbree (viloxazine hydrochloride). Includes dose adjustments, warnings and precautions.

Qelbree is the only non-stimulant ADHD treatment that can be sprinkled, making it easier to take for patients who are unable to swallow capsules. Learn more about the first non-stimulant approved for adult ADHD in over 20 years.

Qelbree is a once-a-day ADHD medication for children aged 6-17 years. In clinical trials, Qelbree has been proven to help reduce ADHD symptoms, with manageable side effects when taken as directed. Qelbree can easily fit into your and your child’s schedule.

2025年3月31日 · Qelbree and Strattera have boxed warnings related to the risk of suicidal thoughts or behaviors in certain people. A boxed warning is the most serious warning from the Food and Drug Administration ...

2021年5月25日 · Qelbree is a prescription medicine used to treat attention deficit hyperactivity disorder (ADHD) in children 6 to 17 years of age. It is not known if Qelbree is safe and effective in children less than 6 years of age. What is the most important information I should know about Qelbree? Qelbree can cause serious side effects, including: